Sort
166,118 grants matching “stem cells”
Isolation, characterization and translational development of glioma stem cells
$1,028,400Luis F Parada · Sloan-Kettering Inst Can Research · R35 · FY2017 · CA
Isolation, characterization and translational development of glioma stem cells
$1,028,400Luis F Parada · Sloan-Kettering Inst Can Research · R35 · FY2018 · CA
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer
$1,028,395Moorthy P. Ponnusamy · University Of Nebraska Medical Center · R01 · FY2025 · CA
Gene-targeting and Animal Model Unit
$1,028,394Toren Finkel · National Heart, Lung, And Blood Institute · ZIC · FY2013 · HL
Oncogenic NOTCH Signaling
$1,028,373Jon C Aster · Brigham And Women'S Hospital · P01 · FY2010 · CA
DSU Sub-Project 1
$1,028,338Harb S. Dhillon · Delaware State University · P20 · FY2016 · GM
Actin assembly and clathrin-mediated endocytosis in yeast and mammals
$1,028,284David G. Drubin · University Of California Berkeley · R35 · FY2022 · GM
Immune reconstitution following autologous and allogeneic stem cell transplant
$1,028,281Francis Flomerfelt · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Presence and role of Enteroendocrine Cells Residing at the Intestinal Crypt Base
$1,028,234Stephen Wank · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Mechanisms and clinical effects of microchimerism in transfused trauma patients
$1,028,163Michael Paul Busch · Vitalant · R01 · FY2006 · HL
Actin assembly and clathrin-mediated endocytosis in yeast and mammals
$1,028,100David G. Drubin · University Of California Berkeley · R35 · FY2021 · GM
Skeletal stem cell plasticity in craniofacial bone diseases.
$1,027,998Noriaki Ono · University Of Texas Hlth Sci Ctr Houston · R35 · FY2024 · DE
The Inveon PET/CT for Pre-Clinical Oncology Research
$1,027,842Pat B Zanzonico · Sloan-Kettering Inst Can Research · S10 · FY2012 · OD
New Ways of Targeting K-Ras
$1,027,806Frank Patrick McCormick · University Of California, San Francisco · R35 · FY2021 · CA
Platform technology to identify and develop first-in-class anti-fibrotic therapeutics through inhibition of collagen CP4H
$1,027,583Ronald Lennox · Adiutrix Therapeutics · R42 · FY2025 · HL
A planning project to pilot test and optimize dietary approaches to slow aging and design a long-term trial
$1,027,463Corby K Martin · Lsu Pennington Biomedical Research Ctr · U01 · FY2023 · AG
Development of a Synthetic, Cell-Permeable Peptide for the Inhibition of CDK5-p25 Hyperactivity in Amyotrophic Lateral Sclerosis
$1,027,314John Kent Werner · Cogentis Therapeutics, Inc. · R44 · FY2022 · NS
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,027,273Aaron D. Gitler · Stanford University · R35 · FY2018 · NS
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,027,273Aaron D. Gitler · Stanford University · R35 · FY2019 · NS
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,027,273Aaron D. Gitler · Stanford University · R35 · FY2022 · NS
iPS-technology and patient specific disease models
$1,027,093Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Biomimetic Macrophage Membrane-Coated Nanosponges: A Novel Therapeutic for Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Hospital-Associated Pneumonia
$1,027,000Victor Nizet · University Of California, San Diego · R01 · FY2023 · AI
An iPSC based platform for functionally assessing genetic and environmental risk
$1,026,973Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2014 · NS
Studies of neurocysticercosis and animal cestode infections
$1,026,875Theodore Nash · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Protective factors and mechanisms
$1,026,777Doo Yeon Kim · Boston University Medical Campus · U19 · FY2023 · AG